Tables 2.4 - 2.8 for Cancer Incidence 1992-1996
| Table 2.4 |
Median
Age at Diagnosis for Selected Cancers, Minnesota 1992-1996 |
| Table 2.5 |
Number
of Cancers Expected in the Lifetimes of 1,000 Minnesotans |
| Table 2.6 |
Detailed
Distribution of Cancers (Including Benign Tumors of the Central Nervous
System) in Minnesota Children (0-14 years), 1992-1996 |
| Table 2.7 |
Childhood
(0-14 years) Cancer Incidence Rates by Sex, All Races, Minnesota 1992-1996 |
| Table 2.8 |
Number
of Cancers Expected per 1,000 Children by Age 15 |
Table 2.4:
Median Age* at Diagnosis for Selected Cancers,
Minnesota 1992-1996
| |
Median Age at Diagnosis
(years) |
| Cancer |
Males |
Females |
| Oral
Cavity |
65 |
68 |
| Esophagus |
68 |
73 |
| Stomach |
72 |
76 |
| Small
Intestine |
67 |
71 |
| Colon |
71 |
75 |
| Rectum |
69 |
72 |
| Liver |
67 |
70 |
| Gallbladder |
75 |
75 |
| Pancreas |
68 |
71 |
| Larynx |
66 |
63 |
| Lung |
69 |
68 |
| Trachea
and Pleura |
68 |
70 |
| Bones
and Joints |
31 |
45 |
| Soft
Tissues |
61 |
60 |
| Melanoma |
59 |
50 |
| Breast |
70 |
65 |
| Cervix |
- |
43 |
| Uterus |
- |
66 |
| Ovary |
- |
61 |
| Vulva |
- |
72 |
| Prostate |
71 |
- |
| Testis |
33 |
- |
| Bladder |
72 |
75 |
| Kidney |
66 |
68 |
| Eye |
61 |
60 |
| Brain |
52 |
56 |
| Thyroid |
50 |
41 |
| Hodgkin's
Lymphoma |
37 |
31 |
| Non-Hodgkin's
Lymphoma |
65 |
70 |
| Multiple
Myeloma |
72 |
72 |
| Lymphocytic
Leukemia |
67 |
69 |
| Myelocytic
Leukemia |
69 |
71 |
| All
Leukemias |
67 |
69 |
| All
Cancers |
69 |
67 |
*Age at which 50 percent of the patients were younger and
50 percent were older
when diagnosed with a specific cancer.
Table 2.5:
Number of Cancers Expected in the Lifetimes of 1,000 Minnesotans*
| Cancer |
Males |
Females |
| Oral
Cavity |
16 |
9 |
| Esophagus |
8 |
2 |
| Stomach |
10 |
5 |
| Small
Intestine |
2 |
2 |
| Colon |
41 |
46 |
| Rectum |
16 |
12 |
| Liver |
4 |
2 |
| Gallbladder |
1 |
2 |
| Pancreas |
11 |
9 |
| Larynx |
6 |
2 |
| Lung |
72 |
52 |
| Trachea
and Pleura |
3 |
|
| Bones
and Joints |
1 |
1 |
| Soft
Tissues |
3 |
3 |
| Melanoma |
18 |
11 |
| Breast |
1 |
141 |
| Cervix |
- |
7 |
| Uterus |
- |
29 |
| Ovary |
- |
18 |
| Vulva |
- |
3 |
| Prostate |
172 |
- |
| Testis |
4 |
- |
| Bladder |
35 |
14 |
| Kidney |
14 |
8 |
| Eye |
1 |
|
| Brain |
6 |
4 |
| Thyroid |
2 |
7 |
| Hodgkin's
Lymphoma |
2 |
2 |
| Non-Hodgkin's
Lymphoma |
24 |
20 |
| Multiple
Myeloma |
7 |
4 |
| Lymphocytic
Leukemia |
9 |
6 |
| Myelocytic
Leukemia |
6 |
5 |
| All
Leukemias |
17 |
12 |
| All
Cancers |
518 |
447 |
*Based
on MCSS 1996 cancer incidence and 1996 all cause mortality.
Expectation less than
0.5.
Table 2.6:
Detailed Distribution of Cancers
(Including Benign Tumors of the Central Nervous System)
in Minnesota Children (0-14 years), 1992-1996*
|
Diagnostic Group |
Males
N (%)
|
Females
N (%) |
| Leukemias |
135 (29.8) |
91 (26.0) |
Acute lymphocytic leukemia
|
113 (25.0) |
74 (21.1) |
Acute non-lymphocytic leukemia
|
17 (3.8) |
11 (3.1) |
Chronic myeloid leukemia
|
1 (0.2) |
3 (0.9) |
| Lymphomas
and other reticuloendothelial malignancies |
54 (11.9) |
27 (7.7) |
Hodgkin's disease
|
18 (4.0) |
6 (1.7) |
Non-Hodgkin's lymphoma
|
21 (4.6) |
14 (4.0) |
Burkitt's lymphoma
|
11 (2.4) |
4 (1.1) |
| Central
nervous system and miscellaneous intracranial and intraspinal neoplasms |
119 (26.3) |
88 (25.1) |
Ependymoma
|
15 (3.3) |
7 (2.0) |
Astrocytoma
|
48 (10.6) |
32 (9.1) |
Medulloblastoma
|
22 (4.9) |
18 (5.1) |
Other glioma
|
12 (2.6) |
6 (1.7) |
Miscellaneous intracranial and intraspinal neoplasms
|
20 (4.4) |
24 (6.9) |
| Sympathetic
nervous system malignancies |
31 (6.8) |
31 (8.9) |
Neuroblastoma and ganglioneuroblastoma
|
29 (6.4) |
29 (8.3) |
| Retinoblastoma |
7 (1.5) |
9 (2.6) |
| Renal
malignancies |
22 (4.9) |
24 (6.9) |
Wilm's tumor
|
22 (4.9) |
24 (6.9) |
| Hepatic
malignancies |
7 (1.5) |
5 (1.4) |
Hepatoblastoma
|
6 (1.3) |
5 (1.4) |
| Malignant
bone tumors |
25 (5.5) |
14 (4.0) |
Osteosarcoma
|
13 (2.9) |
8 (2.3) |
Ewing's sarcoma
|
8 (1.8) |
6 (1.7) |
| Soft
tissue sarcomas |
27 (6.0) |
17 (4.9) |
Rhabdomyosarcoma, embryonal sarcoma and soft tissue Ewing's tumor
|
19 (4.2) |
7 (2.0) |
Fibrosarcoma, neurofibrosarcoma, and other fibromatous neoplasms
|
5 (1.1) |
6 (1.7) |
| Germ
cell, trophoblastic, and other gonadal malignancies |
11 (2.4) |
21 (6.0) |
Non-gonadal germ cell and trophoblastic neoplasms
|
8 (1.7) |
10 (2.9) |
Gonadal germ cell and trophoblastic neoplasms
|
3 (0.7) |
10 (2.9) |
| Carcinoma
and other malignant epithelial neoplasms |
15 (3.3) |
23 (6.6) |
| All
pediatric cancers |
453 (100.0) |
350 (100.0) |
* International Classification of Childhood Cancer Groupings
Table 2.7:
Childhood (0-14 years) Cancer Incidence
Rates by Sex, All Races, Minnesota 1992-1996*
| |
Minnesota |
|
United States |
| Site |
Males |
Females |
Both
Sexes |
|
Males |
Females |
Both
Sexes |
| Hodgkin's
Disease |
0.7 |
0.2 |
0.5 |
|
0.5 |
0.5 |
0.5 |
| Bones
and Joints |
1.0 |
0.6 |
0.8 |
|
0.7 |
0.8 |
0.7 |
| Kidney |
0.8 |
0.9 |
0.8 |
|
0.9 |
0.8 |
0.8 |
| Non-Hodgkin's
Lymphoma |
1.2 |
0.7 |
1.0 |
|
1.3 |
0.5 |
0.9 |
| Soft
Tissue |
1.1 |
1.0 |
1.1 |
|
0.9 |
0.8 |
0.9 |
| Brain
and CNS (malignant) |
3.2 |
2.1 |
2.7 |
|
3.5 |
3.0 |
3.3 |
| Acute
Lymphocytic Leukemia |
4.2 |
2.9 |
3.6 |
|
3.4 |
2.8 |
3.1 |
| All
Cancers |
16.5 |
12.9 |
14.7 |
|
14.9 |
13.1 |
14.1 |
* Average annual rates per 100,000 and age-adjusted to the 1970 U.S.
standard population.
Data from the NCI's SEER
program for all races combined, 1991-1995.
Table 2.8:
Number of Cancers Expected
per 1,000 Children by Age 15.*
|
Males |
Females |
Males and Females |
|
2.5 |
2.1 |
2.3 |
*Based on Minnesota 1996 cancer incidence and 1996 all-cause mortality.
|
